19079-Solid Tumors-NA-988

Solid Tumors

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number:

  • Address

910 E 26th St, Suite 200
Minneapolis, MN 55404
P: (612) 884-6300

Search by practice name, trial titles, indicators and specific disease types.